Background Investigation Methods, Corporate Intelligence & Due Diligence, e-Discovery Techniques, Investigation & Intelligence Feeds, Judgment Enforcement, Legal Enforcement Cases, Legal Ethics & Intelligence, Legal Technology & Intelligence, Witness Credibility Analysis

Celltrion launches Actemra® Biosimilar Avtozma®

Posted by author-avatar
0
Test Logo Transparent

On October 2, 2025, Celltrion launched Avtozma® (tocilizumab-anoh), in intravenous and subcutaneous formulations, as the third biosimilar of Genentech’s Actemra® (tocilizumab)….
By: Venable LLP

Newer
Furloughed IRS Lawyer Opens Hot Dog Cart, Finally Starts Serving The Public
Back to list
Older Navigating the Shift from FIRE to IRIS – IRS Changes for Forms 1098, 1099 and other Information Return Filers

Leave a Reply

Your email address will not be published. Required fields are marked *